Cost-utility analysis of disease-modifying drugs in relapsing-remitting multiple sclerosis in Iran. Imani A, Golestani M Iran J Neurol. 2012; 11(3):87-90. PMID: 24250871. Abstract CommentRecommendBookmarkWatch